Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis

NCT07299695 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

196

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis
Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Intravenous immunoglobulin (IVIG)
DRUG: Usual treatment

Sponsor

Argyrios Tzouvelekis